Experiments for taxon Monomorium indicum (FORMICIDAE)

Experiments (12 results)

12 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
102770	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INSECTICIDE ACTIVITY	Monomorium indicum (FORMICIDAE)	PYRROLIDINE,2-BUTYL-5-(4-PENTENYL): TRANS:
102778	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Monomorium indicum (FORMICIDAE)	PYRROLIDINE,2-BUTYL-5-(4-PENTENYL): CIS:
102780	IDENTIFICATION IN BY GC/MS		Monomorium indicum (FORMICIDAE)	PYRROLIDINE,2-BUTYL-5-HEPTYL: N-METHYL: TRANS:PYRROLIDINE,2-BUTYL-5-HEPTYL: TRANS:PYRROLIDINE,5-(5-HEXENYL)-2-PENTYL: TRANS:PYRROLIDINE,5-HEPTYL-2-(5-HEXEN-1-YL):FARNESENEPYRROLIDINE,2-HEXYL-5-PENTYL: TRANS:PYRROLIDINE,2-BUTYL-5-PENTYL: CIS:
102777	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Monomorium indicum (FORMICIDAE)	PYRROLIDINE,2-BUTYL-5-(4-PENTENYL): N-METHYL: TRANS:
102771	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Monomorium indicum (FORMICIDAE)	PYRROLIDINE,5-(5-HEXENYL)-2-(4-PENTENYL): TRANS:
102776	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Monomorium indicum (FORMICIDAE)	PYRROLIDINE,2-BUTYL-5-(6-HEPTENYL): TRANS:
102769	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Monomorium indicum (FORMICIDAE)	PYRROLIDINE,2-BUTYL-5-(4-PENTENYL): TRANS:
102772	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INSECTICIDE ACTIVITY	Monomorium indicum (FORMICIDAE)	PYRROLIDINE,5-(5-HEXENYL)-2-(4-PENTENYL): TRANS:
102775	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Monomorium indicum (FORMICIDAE)	PYRROLIDINE,5-HEPTYL-2-HEXYL: TRANS:
102779	IDENTIFICATION IN BY GC/MS		Monomorium indicum (FORMICIDAE)	PYRROLIDINE,2-BUTYL-5-PENTYL: TRANS:
102773	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Monomorium indicum (FORMICIDAE)	PYRROLIDINE,5-(6-HEPTENYL)-2-(5-HEXENYL): TRANS:
102774	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INSECTICIDE ACTIVITY	Monomorium indicum (FORMICIDAE)	PYRROLIDINE,5-(6-HEPTENYL)-2-(5-HEXENYL): TRANS: